A second Phase 1 human pharmacokinetic trial of LTX-04

Trial Profile

A second Phase 1 human pharmacokinetic trial of LTX-04

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Hydromorphone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Jun 2017 Results published in an Acura Pharmaceuticals media release.
    • 25 May 2017 New trial record
    • 18 May 2017 The Company expects dosing to complete by the end of May with topline results announced in June according to an Acura Pharmaceutical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top